Provigil, Modavigil, Modiodal, Modalert, Modvigil...? - the brain boosting drug
Modafinil (chemically called 2-[(diphenylmethyl)sulfinyl]acetamide) is a drug produced by neurophysiology medicine professor Michel Jouvet and Lafon Laboratories in France. Though most commonly called Modafinil, it can be sold worldwide under various brands including Provigil (purchased from UK, Croatia, Poland, Hong Kong, Italy, South Korea, Thailand, UAE), Modavigil (purchased in Australia), Modiodal (purchased from France, Japan, Singapore), Modalert, Modapro, Modvigil (the 3 purchased from India), Modasomil (sold in Switzerland), and SpierX (purchased from Malaysia).
It is a powerful stimulant that only improves memory, intellectual keenness, and other mental activities, but is incredibly efficient at restoring your brains cognitive functions during periods of decreased wakefulness.
The drug operates by inducing your system to improve the production of monoamines, that happen to be specific neurotransmitters. These neurotransmitters stimulate the hypothalamus, which can be accountable for producing hormones that control sleep and the circadian rhythm, among many things.
Created to treat signs of narcolepsy (installments of uncontrollable sleep), it helps restore alertness and fight tiredness and fatigue.
Early Development
Modafinil was originally synthesized inside the 1970�s in France. After studies were carried out 1986, it had been observed that only was this drug effective for treating narcolepsy, it also temporarily reduced the call to sleep in healthy patients.
In 1993, Lafon Laboratories leased the rights to Modafinil into a company in the us called Cephalon. After 5 years, it was officially FDA approved and sold as Provigil as being a remedy against narcolepsy and osa.
In 2007, the FDA approved Armodafinil, hitherto sold as Nuvigil. Armodafinil is technically considered an enantiomer of Modafinil. Armodafinil solely consists of the (R)-enatiomer, the ingredient of Modafinil. This new formula was marketed to offset the financial losses the result of a market future flooded with cheap generic drugs, as Cephalon was seeking to lose the exclusive marketing rights for Modafinil. Armodafinil would have been to be utilized for a treatment for narcolepsy, shift work sleep problem, and osa.
This year, the FDA refused a request by Cephalon to advertise Nuvigil because the first pharmaceutical treatment for jet lag.
Primary Indications
Modafinil�s primary indication is for the treating narcolepsy, however it's often prescribed for all those with adhd, treatment-resistant depression, other antidepressant therapies, and ms (MS). Exploratory studies are also turning up promising recent results for the drug�s possible benefits in remedying depressive symptoms.
Narcolepsy can be a neurological disorder that creates uncontrollable daytime sleepiness that's a result of the deficiencies in orexin peptides inside the brain, which can be to blame for controlling wakefulness and sleep-suppression. Modafinil targets these orexin neurons and activates them, which experts claim promotes wakefulness.- the brain boosting drug
Other common illnesses and diseases it is used to treat include fibromyalgia, chronic fatigue syndrome, myotonic dystrophy, ms (MS), cerebral palsy, and Parkinson�s disease.